Literature DB >> 22458937

Cardiac myosin binding protein C and its phosphorylation regulate multiple steps in the cross-bridge cycle of muscle contraction.

Arthur T Coulton1, Julian E Stelzer.   

Abstract

Cardiac myosin binding protein C (c-MyBPC) is a thick filament protein that is expressed in cardiac sarcomeres and is known to interact with myosin and actin. While both structural and regulatory roles have been proposed for c-MyBPC, its true function is unclear; however, phosphorylation has been shown to be important. In this study, we investigate the effect of c-MyBPC and its phosphorylation on two key steps of the cross-bridge cycle using fast reaction kinetics. We show that unphosphorylated c-MyBPC complexed with myosin in 1:1 and 3:1 myosin:c-MyBPC stoichiometries regulates the binding of myosin to actin (K(D)) cooperatively (Hill coefficient, h) (K(D) = 16.44 ± 0.33 μM, and h = 9.24 ± 1.34; K(D) = 11.48 ± 0.75 μM, and h = 3.54 ± 0.67) and significantly decelerates the ATP-induced dissociation of myosin from actin (K(1)k(+2) values of 0.12 ± 0.01 and 0.22 ± 0.01 M(-1) s(-1), respectively, compared with a value of 0.42 ± 0.01 M(-1) s(-1) for myosin alone). Phosphorylation of c-MyBPC abolished the regulation of the association phase (K(1)k(+2) values of 0.32 ± 0.02 and 0.33 ± 0.01 M(-1) s(-1) at 1:1 and 3:1 myosin:c-MyBPC ratios, respectively) and also accelerated the dissociation of myosin from actin (K(1)k(+2) values of 0.23 ± 0.01 and 0.29 ± 0.01 M(-1) s(-1) at a 1:1 and 3:1 myosin:c-MyBPC ratios, respectively) relative to the dissociation of myosin from actin in the presence of unphosphorylated c-MyBPC. These results indicate a direct effect of c-MyBPC on cross-bridge kinetics that is independent of the thin filament that together with its phosphorylation provides a mechanism for fine-tuning cross-bridge behavior to match the contractile requirements of the heart.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458937      PMCID: PMC5598764          DOI: 10.1021/bi300085x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  65 in total

1.  Energetics and mechanism of actomyosin adenosine triphosphatase.

Authors:  H D White; E W Taylor
Journal:  Biochemistry       Date:  1976-12-28       Impact factor: 3.162

2.  Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain.

Authors:  John M Squire; Pradeep K Luther; Carlo Knupp
Journal:  J Mol Biol       Date:  2003-08-15       Impact factor: 5.469

Review 3.  Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins.

Authors:  R John Solaro
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

4.  Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.

Authors:  Samantha P Harris; Christopher R Bartley; Timothy A Hacker; Kerry S McDonald; Pamela S Douglas; Marion L Greaser; Patricia A Powers; Richard L Moss
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

5.  The interaction of C-protein with heavy meromyosin and subfragment-2.

Authors:  R Starr; G Offer
Journal:  Biochem J       Date:  1978-06-01       Impact factor: 3.857

Review 6.  Regulation of cardiac contractile function by troponin I phosphorylation.

Authors:  Joanne Layland; R John Solaro; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

7.  The N-terminal domains of myosin binding protein C can bind polymorphically to F-actin.

Authors:  Albina Orlova; Vitold E Galkin; Cy M J Jeffries; Edward H Egelman; Jill Trewhella
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

8.  Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domain.

Authors:  Abbey Weith; Sakthivel Sadayappan; James Gulick; Michael J Previs; Peter Vanburen; Jeffrey Robbins; David M Warshaw
Journal:  J Mol Cell Cardiol       Date:  2011-09-25       Impact factor: 5.000

Review 9.  Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.

Authors:  Cecily E Oakley; Brett D Hambly; Paul M G Curmi; Louise J Brown
Journal:  Cell Res       Date:  2004-04       Impact factor: 25.617

10.  Contribution of the myosin binding protein C motif to functional effects in permeabilized rat trabeculae.

Authors:  Maria V Razumova; Kristina L Bezold; An-Yue Tu; Michael Regnier; Samantha P Harris
Journal:  J Gen Physiol       Date:  2008-11       Impact factor: 4.086

View more
  24 in total

1.  The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.

Authors:  Kenneth S Gresham; Ranganath Mamidi; Julian E Stelzer
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

2.  Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.

Authors:  Kristin Wilson; Anuradha Guggilam; T Aaron West; Xiaojin Zhang; Aaron J Trask; Mary J Cismowski; Pieter de Tombe; Sakthivel Sadayappan; Pamela A Lucchesi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

3.  Impact of heart rate on cross-bridge cycling kinetics in failing and nonfailing human myocardium.

Authors:  Jae-Hoon Chung; Nima Milani-Nejad; Jonathan P Davis; Noah Weisleder; Bryan A Whitson; Peter J Mohler; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-26       Impact factor: 4.733

4.  Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function.

Authors:  Michael J Previs; Ji Young Mun; Arthur J Michalek; Samantha Beck Previs; James Gulick; Jeffrey Robbins; David M Warshaw; Roger Craig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-23       Impact factor: 11.205

5.  Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function.

Authors:  Paola C Rosas; Yang Liu; Mohamed I Abdalla; Candice M Thomas; David T Kidwell; Giuseppina F Dusio; Dhriti Mukhopadhyay; Rajesh Kumar; Kenneth M Baker; Brett M Mitchell; Patricia A Powers; Daniel P Fitzsimons; Bindiya G Patel; Chad M Warren; R John Solaro; Richard L Moss; Carl W Tong
Journal:  Circ Heart Fail       Date:  2015-03-04       Impact factor: 8.790

6.  Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.

Authors:  Ranganath Mamidi; Kenneth S Gresham; Amy Li; Cristobal G dos Remedios; Julian E Stelzer
Journal:  J Mol Cell Cardiol       Date:  2015-06-20       Impact factor: 5.000

7.  Rate-dependent force, intracellular calcium, and action potential voltage alternans are modulated by sarcomere length and heart failure induced-remodeling of thin filament regulation in human heart failure: A myocyte modeling study.

Authors:  Melanie A Zile; Natalia A Trayanova
Journal:  Prog Biophys Mol Biol       Date:  2015-12-25       Impact factor: 3.667

8.  S-Nitrosylation of Sarcomeric Proteins Depresses Myofilament Ca2+)Sensitivity in Intact Cardiomyocytes.

Authors:  Cícero Figueiredo-Freitas; Raul A Dulce; Matthew W Foster; Jingsheng Liang; Aline M S Yamashita; Frederico L Lima-Rosa; J Will Thompson; M Arthur Moseley; Joshua M Hare; Leonardo Nogueira; Martha M Sorenson; José Renato Pinto
Journal:  Antioxid Redox Signal       Date:  2015-11-01       Impact factor: 8.401

9.  Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy.

Authors:  Ranganath Mamidi; Jiayang Li; Kenneth S Gresham; Julian E Stelzer
Journal:  Pflugers Arch       Date:  2013-12-06       Impact factor: 3.657

Review 10.  Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.

Authors:  Joshua B Holmes; Chang Yoon Doh; Ranganath Mamidi; Jiayang Li; Julian E Stelzer
Journal:  Expert Opin Drug Discov       Date:  2020-02-18       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.